FDA Announces Intention to Regulate LDTs as Devices

The agency releases its long-awaited proposed frameworkAugust 7, 2014

Jeff Gibbs authored and article “FDA Announces Intention to Regulate LDTs as Devices” for Genetic Engineering & Biotechnology News

In 1992, the Food and Drug Administration (FDA) first stated that it had authority to regulate laboratory-developed tests. On July 31, FDA took its biggest step toward invoking this asserted authority by unveiling its Framework for Regulatory Oversight of Laboratory-Developed Tests (LDTs).

Additional information available here.